Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: General

Eyes on Washington: Federal Health Care Grant Notification Service

Monday, August 17, 2015   (0 Comments)
Posted by: TCAA Staff
Share |

Eyes on Washington: Federal Health Care Grant Notification Service

 

Grant Opportunities for August 10, 2015 through August 17, 2015

 

Visit Holland & Knight online

  

New Federal Health Care Grant Opportunities Announced for:

ยท         National Institutes of Health (NIH)

 

NON-NIH Funding Opportunity Announcements:

 

No further Non-NIH funding opportunities have been announced at this time.

 

NIH Funding Opportunity Announcements:

 

NIH: Urological Epidemiology (UroEpi) Research Training Program (T32)

Funding Opportunity Number: RFA-DK-15-008

This Funding Opportunity Announcement (FOA) invites research training (T32 program) applications in the area of epidemiology of benign urological conditions. NIDDK desires institutional support of student trainees at the predoctoral level with an interest in the epidemiology of benign urological conditions within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to develop the skills necessary to initiate an independent research career in this area. It is expected that the trainees would go on to careers in academic research. This funding opportunity was announced on August 14, 2015. A letter of intent is due October 23, 2015. The application deadline is November 23, 2015. For more information, please visit NIH's Funding Opportunity Announcement.

 

NIH: Novel Nucleic Acid Sequencing Technology Development (R01)

Funding Opportunity Number: RFA-HG-15-032

This Funding Opportunity Announcement (FOA) solicits R01 grant applications to develop novel technologies that will enable new approaches to DNA and direct RNA sequencing. Applicants may propose to develop novel complete sequencing systems, investigate challenges underlying key novel system components, or propose improvements of at least an order of magnitude improvement to existing systems. Exploration of methods other than those currently in use is highly encouraged. High-risk/high-payoff applications are appropriate to achieve the goals of this FOA. This funding opportunity was announced on August 17, 2015. The application deadline is August 27, 2017. For more information, please visit NIH's Funding Opportunity Announcement.

 

NIH: Novel Nucleic Acid Sequencing Technology Development (R21)

Funding Opportunity Number: RFA-HG-15-031

This Funding Opportunity Announcement (FOA) solicits R21 grant applications to develop novel technologies that will enable new approaches to DNA and direct RNA sequencing. Applicants may propose to develop novel complete sequencing systems, investigate challenges underlying key novel system components, or propose improvements of at least an order of magnitude improvement to existing systems. Exploration of methods other than those currently in use is highly encouraged. High-risk/high-payoff applications are appropriate to achieve the goals of this FOA. This funding opportunity was announced on August 17, 2015. The application deadline is September 27, 2017. For more information, please visit NIH's Funding Opportunity Announcement.

 

NIH: Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19)

Funding Opportunity Number: PAR-15-330

The goal of the Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) Funding Opportunity Announcement (FOA) is to facilitate the translation of sufficiently advanced, innovative and promising vaccine candidates into early clinical testing. The IPCAVD program is designed to enable a multi-disciplinary team of investigators to complete all steps necessary from down-selection of a vaccine candidate through CGMP manufacture/testing/product release and into clinical trials. A preclinical research application alone is not sufficient for this announcement. Awards will provide the critical resources to allow the advancement of vaccine concepts to clinical trials within the project period of the award. However, this funding opportunity will not provide funds for conducting the clinical studies; applicants are encouraged to collaborate with NIAID-supported clinical trial networks or to develop other relationships to support the clinical studies. Investigators are expected to begin clinical studies by the end of the award. This funding opportunity was announced on August 14, 2015. The application deadline is March 9, 2018. For more information, please visit NIH's Funding Opportunity Announcement.

 

NIH: Urological Epidemiology (UroEpi) Institutional Research Career Development Program (K12)

Funding Opportunity Number: RFA-DK-15-007

This Funding Opportunity Announcement (FOA) invites institutional career development program (K12) applications in the area of epidemiology of benign urological conditions. This institutional program will provide scholars with research and/or clinical doctoral degrees (including MD, PhD, MD/PhD, DrPH) with the skills and resources necessary to initiate an independent research career in the epidemiology of benign urological conditions within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This funding opportunity was announced on August 13, 2015. A letter of intent is due on October 23, 2015. The application deadline is November 23, 2015. For more information, please visit NIH's Funding Opportunity Announcement.

 

NIH: Improving Health and Reducing Cardiometabolic Risk in Youth with Serious Emotional Disturbance and Young Adults with Severe Mental Illness (R01)

Funding Opportunity Number: RFA-MH-16-600

This Funding Opportunity Announcement (FOA) aims to support research grants focused on rigorous effectiveness testing of innovative services interventions that demonstrably reduce the prevalence and magnitude of common health risk factors related to shortened lifespan in youth with serious emotional disturbance (SED) and young adults with severe mental illness. These risk factors include, but are not limited to, smoking, obesity, hypertension, dyslipidemia, low physical activity, substance use, poor fitness and diet. This FOA aims to generate the service delivery knowledge necessary to achieve 100% screening of this population for common, cardiometabolic risks and 100% referral to appropriate care to manage the identified risks. This FOA aims to support population-based approaches to prevention, identification and intervention, i.e., targeting cardiometabolic risk in entire populations of youth with SED and/or young adults with SMI within a given community or healthcare setting. This funding opportunity was announced on August 12, 2015. A letter of intent is due on October 6, 2015. The application deadline is November 6, 2015. For more information, please visit NIH's Funding Opportunity Announcement.

 

NIH: Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp)

Funding Opportunity Number: PA-15-329

The NIH Office of the Director announces the availability of administrative supplements to expand existing research to focus on Sexual and Gender Minority (SGM) health. SGM populations include, but are not limited to, lesbian, gay, bisexual, and transgender people, and individuals with differences or disorders of sexual development (sometimes referred to as intersex or as specific diagnoses). This trans-NIH effort, which involves multiple Institutes, Centers and Offices from across NIH, is intended to encourage investigation in this underrepresented growing field of research. To increase our collective understanding of the broad range of the health needs of SGM populations, the supplement will focus on areas of specific research interest beyond HIV/AIDS, including, but not limited to: studies on increased disease risk; behavioral and social health; approaches to personalized medicine; access to care; reproductive and sexual development; and resilience. This funding opportunity was announced on August 11, 2015. The application deadline is November 30, 2015. For more information, please visit NIH's Funding Opportunity Announcement.

 

NIH: Short-term Measurements of Improved Physical and Molecular Resilience in Pre-clinical Models (R01)

Funding Opportunity Number:  RFA-AG-16-006

This Funding Opportunity Announcement (FOA) invites applications to develop short-term surrogate tests that provide a comprehensive measure of resilience in animal models of aging. Applicants may also include aims to assess resilience in humans to identical or analogous stressors to those proposed for their animal model studies. Resilience is defined here as the ability of an organism to adequately respond to physical or molecular challenges or stresses. Greater resilience has been hypothesized to correlate with longevity and better healthspan, but appropriate methodology to test this in animal models is currently lacking. The purpose of this FOA is to develop tests that can be used to measure resilience to physical or molecular stresses, but does not include psychological or social stressors. The outcomes should lead to short-term tests of resilience that are predictive of subsequent health. In the context of animal studies, this predictability should be tested against manipulations known to increase lifespan and healthspan. This funding opportunity was announced on August 11, 2015. A letter of intent is due on October 4, 2015. The application deadline is November 4, 2015. For more information, please visit NIH's Funding Opportunity Announcement.

 

NIH: Oral HIVacc: Oral Mucosal Immunization Approaches for HIV Prevention (R01)

Funding Opportunity Number: RFA-DE-16-006

This Funding Opportunity Announcement (FOA) solicits research projects to develop and test novel HIV vaccines for direct administration into oral lymphoid tissues to trigger protective, local and systemic immunity. Specifically, this FOA seeks research projects to: 1) define the mechanisms by which direct HIV vaccination of oral lymphoid tissues induce oral innate as well as local and systemic adaptive immune responses; 2) determine the mechanisms by which new adjuvants used together with oral HIV vaccine candidates enhance local and systemic immunity; 3) test innovative, oral vaccine vectors expressing HIV vaccine antigens to trigger protective immunity; 4) compare different HIV vaccine immunization strategies and schemes for the oral mucosa to maximize protection; and 5) delineate the role of dynamic changes in oral and immune cell subsets and their interactions to enhance immunity upon oral HIV vaccination. This funding opportunity was announced on August 10, 2015. The application deadline is November 23, 2016. For more information, please visit NIH's Funding Opportunity Announcement.

 

NIH: Ethical, Legal and Policy Issues in HIV Research with Key Populations (R21)

Funding Opportunity Number: PAR-15-327

This Funding Opportunity Announcement (FOA) encourages applications to analyze and address ethical, legal, or policy challenges specific to work with key populations in HIV research or health care. Proposed projects should be focused on ethical, legal or policy challenges in relation to research studies or program implementation for HIV or associated co-morbidities, affecting one or more of the following key populations: (1) men who have sex with men; (2) people who inject drugs; (3) people in prisons and other closed settings; (4) sex workers; (5) transgender people or (6) adolescent girls and young women at high risk of HIV acquisition or who are living with HIV. This FOA encourages both empirical and conceptual research projects addressing these topics. This funding opportunity was announced on August 10, 2015. The application deadline is September 7, 2018. For more information, please visit NIH's Funding Opportunity Announcement.


Association Management Software Powered by YourMembership  ::  Legal